A promising strategy to control life-threatening bleeding

Av Vania Morelli
Forsker ved TREC

Anticoagulants, commonly referred to as blood thinners, are drugs used to prevent the

formation of blood clots in the blood vessels or in the heart. A new generation of drugs, the so-called direct oral anticoagulants (DOACs), has emerged as an interesting alternative to warfarin, a well-known anticoagulant by clinicians, for oral anticoagulation. A new study searched for a therapeutic strategy to manage life-threatening bleeding in patients who use DOACs.

Continue reading

Be the first to like.